ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 4802 for:    British | Canada

A Randomized Trial of Letters From Family Physicians to Encourage Screening Mammography in Overdue Women

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02660788
Recruitment Status : Completed
First Posted : January 21, 2016
Last Update Posted : January 21, 2016
Sponsor:
Collaborator:
Canadian Breast Cancer Foundation
Information provided by (Responsible Party):
Alan Nichol, British Columbia Cancer Agency

Brief Summary:
A randomized, double-blinded study conducted in British Columbia, Canada, where there is a publicly funded, organized screening program and screening mammography is recommended at 24-month intervals. Eligible women aged 51-73 years old and overdue for their screening mammogram by 6-24 months are identified in the database of the Screening Mammography Program of BC (SMPBC). Family physicians are recruited by mail and asked to sign letters to the overdue women in their practices. The overdue women are randomized and mailed either the signed reminder letter and the standard reminder postcard, or the standard reminder postcard alone. The primary endpoint is the proportion of overdue women attending a screening mammogram appointment 6 months after the mailing.

Condition or disease Intervention/treatment Phase
Breast Cancer Other: Standard Reminder Postcard Other: Family Physician Reminder Letter Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 5638 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Prevention
Official Title: A Randomised Study of Screening Mammography Return Rates in Overdue Women Due to Standard Screening Mammography Program of British Columbia (Smpbc) Reminders Versus Reminder Letters Signed by Women's Family Physicians
Study Start Date : February 2013
Actual Primary Completion Date : December 2013
Actual Study Completion Date : December 2015

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mammography

Arm Intervention/treatment
Active Comparator: Control Arm
Mail
Other: Standard Reminder Postcard
Experimental: Family Physician Reminder Letter Arm
Mail
Other: Standard Reminder Postcard
Other: Family Physician Reminder Letter



Primary Outcome Measures :
  1. Proportion of overdue women returning for screening mammography [ Time Frame: 6 months ]
    Measured from the date of randomization



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   51 Years to 73 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Active family physicians (family physicians, general practitioners or primary care physicians) who have overdue women in their practice that meet the following criteria:

  • Previously been enrolled in the SMPBC and had a previous normal screening mammogram.
  • Have agreed to being contacted for research on the SMPBC questionnaire
  • Are 6-24 months overdue from their last screening mammogram
  • Live in BC
  • Have listed an active family physician as the contact to receive their mammography results

Exclusion Criteria:

  • Family physicians who do not work in primary care
  • Family physicians who do not have overdue women in their practice

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02660788


Locations
Canada, British Columbia
BC Cancer Agency
Vancouver, British Columbia, Canada, V5Z 4E6
Sponsors and Collaborators
British Columbia Cancer Agency
Canadian Breast Cancer Foundation
Investigators
Principal Investigator: Alan Nichol, MD British Columbia Cancer Agency

Responsible Party: Alan Nichol, Radiation Oncologist, British Columbia Cancer Agency
ClinicalTrials.gov Identifier: NCT02660788     History of Changes
Other Study ID Numbers: H12-02832
First Posted: January 21, 2016    Key Record Dates
Last Update Posted: January 21, 2016
Last Verified: January 2016
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Alan Nichol, British Columbia Cancer Agency:
6-24 months overdue
screening mammography